European Commission authorises second safe and effective vaccine against COVID-19

Jan 05, 2021

European Commission Press release Brussels, 06 Jan 2021 Today, the European Commission has granted a conditional marketing authorisation (CMA) for the COVID‑19 vaccine developed by Moderna, the second COVID-19 vaccine authorised in the EU.


Other news